|
OxtriphyllineDrug - Oxtriphylline The trade name of the product as shown on the labeling.
Dosage -
TABLET, DELAYED RELEASE; ORAL
Active Ingredient(s) -
Oxtriphylline
Strength -
200MG
Applicant -
WATSON LABS
New Drug Application (NDA) Number -
087835
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Aug 25, 1983
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Watson Laboratories Inc
Oxtriphylline
Oxtriphylline 200mg Tablet, Delayed Release; Oral
Trasicor 40mg Capsule; Oral Trasicor 80mg Capsule; Oral Choledyl 100mg/5ml Solution; Oral Oxtriphylline 100mg/5ml Solution; Oral Choledyl 50mg/5ml Syrup; Oral Oxtriphylline Pediatric 50mg/5ml Syrup; Oral Choledyl 100mg Tablet, Delayed Release; Oral Choledyl 200mg Tablet, Delayed Release; Oral Oxtriphylline 100mg Tablet, Delayed Release; Oral NewDrugInformation |